Beyond Colleague Health and Safety
Our research and development (R&D) site in La Jolla, California is a great example of how strong health and safety performance supports colleague engagement and research productivity. The health and safety program at La Jolla is well established, built on risk assessment and control, and driven by leaders. As oncology and vaccine research advances at Pfizer La Jolla, colleague health and safety is routinely under review to ensure all hazards, including new ones, are well characterized and understood. The Environment, Health and Safety (EHS) team at La Jolla enthusiastically applies its contemporary laboratory safety knowledge and experience to support the research teams. Equally important are the research colleagues themselves, as they take ownership of their health and safety, care for each other, and collectively strive for a workplace free of injury and illness. The results speak for themselves. In 2018, La Jolla had very low injury and illness rates, an excellent record of EHS compliance to regulatory and Pfizer Standards, and also achieved important advancements in oncology and vaccine research.
Ian Read: Contributions to Improving Human Health
Albert Bourla: Breakthroughs that Change Patients' Lives
Ushering in a New Era of Pfizer R&D Productivity
Advancing Our Leading JAK Science
Overcoming Therapy-Resistant Disease
Tackling Respiratory Syncytial Virus (RSV) Through Breakthrough Science and Technology
Catalyzing Innovations in Global Health
Contributing to the UN Sustainable Development Goals
Supporting Digital Health Start-Ups
Improving the Health of Women and Their Families